Language selection

Search

Details for: PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Company: SANDOZ CANADA INCORPORATED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02299623PIPERACILLIN AND TAZOBACTAM FOR INJECTIONPIPERACILLIN (PIPERACILLIN SODIUM); TAZOBACTAM (TAZOBACTAM SODIUM)2 G / VIAL; 0.25 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02299631PIPERACILLIN AND TAZOBACTAM FOR INJECTIONPIPERACILLIN (PIPERACILLIN SODIUM); TAZOBACTAM (TAZOBACTAM SODIUM)3 G / VIAL; 0.375 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02299658PIPERACILLIN AND TAZOBACTAM FOR INJECTIONPIPERACILLIN (PIPERACILLIN SODIUM); TAZOBACTAM (TAZOBACTAM SODIUM)4 G / VIAL; 0.5 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02330547PIPERACILLIN AND TAZOBACTAM FOR INJECTIONPIPERACILLIN (PIPERACILLIN SODIUM); TAZOBACTAM (TAZOBACTAM SODIUM)12 G / VIAL; 1.5 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02521539PIPERACILLIN AND TAZOBACTAM FOR INJECTIONPIPERACILLIN (PIPERACILLIN SODIUM); TAZOBACTAM (TAZOBACTAM SODIUM)36 G / VIAL; 4.5 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Piperacillin Containing Products (alone or in combination with tazobactam) - Assessing the Potential Risk of Drug Reaction/Rash with Eosinophilia and Systemic Symptoms (DRESS)
Summary Safety Review - Beta-lactam antibiotics - Assessing the potential risk of severe skin side effects

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: